Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Gedda

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 4, 2012
Nuclisome--targeting the tumor cell nucleusLars Gedda, Katarina Edwards
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 11, 2010
Real-time immunohistochemistry analysis of embedded tissueLars Gedda, Hanna Björkelund, Karl Andersson
Journal of Colloid and Interface Science|June 13, 2020
Effect of gangliosides on structure and integrity of polyethylene glycol (PEG)-stabilized liposomesPhilipp Grad, Lars Gedda, Katarina Edwards
Plos One|November 21, 2012
The HER2-binding affibody molecule (Z(HER2∶342))₂ increases radiosensitivity in SKBR-3 cellsLina Ekerljung, Johan Lennartsson, Lars Gedda
Journal of Molecular Recognition : JMR|January 4, 2011
Avoiding false negative results in specificity analysis of protein-protein interactionsHanna Björkelund, Lars Gedda, Karl Andersson
Plos One|February 10, 2011
Comparing the epidermal growth factor interaction with four different cell lines: intriguing effects imply strong dependency of cellular contextHanna Björkelund, Lars Gedda, Karl Andersson
Oncology Letters|October 5, 2016
17AAG-induced internalisation of HER2-specific Affibody moleculesLovisa Göstring, Sture Lindegren, Lars Gedda
International Journal of Oncology|September 10, 2003
Trastuzumab-conjugated boron-containing liposomes for tumor-cell targeting; development and cellular studiesQichun Wei, Erika Bohl Kullberg, Lars Gedda
Pharmaceutical Research|March 15, 2003
Tumor-cell targeted epiderimal growth factor liposomes loaded with boronated acridine: uptake and processingErika Bohl Kullberg, Marika Nestor, Lars Gedda
Molecular and Clinical Oncology|March 21, 2014
Resolving the EGF-EGFR interaction characteristics through a multiple-temperature, multiple-inhibitor, real-time interaction analysis approachHanna Björkelund, Lars Gedda, Magnus Malmqvist, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|February 4, 2012
Nuclisome--targeting the tumor cell nucleusLars Gedda, Katarina Edwards
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 11, 2010
Real-time immunohistochemistry analysis of embedded tissueLars Gedda, Hanna Björkelund, Karl Andersson
Journal of Colloid and Interface Science|June 13, 2020
Effect of gangliosides on structure and integrity of polyethylene glycol (PEG)-stabilized liposomesPhilipp Grad, Lars Gedda, Katarina Edwards
Plos One|November 21, 2012
The HER2-binding affibody molecule (Z(HER2∶342))₂ increases radiosensitivity in SKBR-3 cellsLina Ekerljung, Johan Lennartsson, Lars Gedda
Journal of Molecular Recognition : JMR|January 4, 2011
Avoiding false negative results in specificity analysis of protein-protein interactionsHanna Björkelund, Lars Gedda, Karl Andersson
Plos One|February 10, 2011
Comparing the epidermal growth factor interaction with four different cell lines: intriguing effects imply strong dependency of cellular contextHanna Björkelund, Lars Gedda, Karl Andersson
Oncology Letters|October 5, 2016
17AAG-induced internalisation of HER2-specific Affibody moleculesLovisa Göstring, Sture Lindegren, Lars Gedda
International Journal of Oncology|September 10, 2003
Trastuzumab-conjugated boron-containing liposomes for tumor-cell targeting; development and cellular studiesQichun Wei, Erika Bohl Kullberg, Lars Gedda
Pharmaceutical Research|March 15, 2003
Tumor-cell targeted epiderimal growth factor liposomes loaded with boronated acridine: uptake and processingErika Bohl Kullberg, Marika Nestor, Lars Gedda
Molecular and Clinical Oncology|March 21, 2014
Resolving the EGF-EGFR interaction characteristics through a multiple-temperature, multiple-inhibitor, real-time interaction analysis approachHanna Björkelund, Lars Gedda, Magnus Malmqvist, et al.
Pageof 7